Back

Multi-Omics Analysis Of Antiviral Interactions Of Elizabethkingia anophelis And Zika Virus

Omme, S. F.; Wang, J.; Sifuna, M.; Rodriguez, J.; Owusu, R.; Goli, M.; Jiang, P.; Purba, W.; Nwaiwu, J.; Brelsfoard, C.; Vigneron, A.; Kramer, L.; Ciota, A.; Mechref, Y.; Onyango, M. G.

2023-12-27 microbiology
10.1101/2023.12.27.573398 bioRxiv
Show abstract

BackgroundThe microbial communities residing in the mosquito midgut play a key role in determining the outcome of mosquito pathogen infection. Elizabethkingia anophelis, originally isolated from the midgut of Anopheles gambiae, has drawn much attention due to its close association with Aedes and Anopheles mosquitoes, primary vectors of dengue virus and malaria parasites, respectively. E. anophelis possesses a broad-spectrum antiviral phenotype, yet a gap in knowledge regarding the mechanistic basis of its interaction with viruses exists. Methodology/Principal findingsTo further understand the antiviral interactions between E. anophelis and Zika virus (ZIKV), we utilized a non-targeted multi-omics approach, analyzing lipids, proteins, and metabolites of cell monolayers co-infected with ZIKV and E. anophelis. We further assessed the gene expression of ZIKV when cultured in the presence of E. anophelis. ZIKV cultured in the presence of E. anophelis resulted in an attenuated replicative fitness and unproductive virus infection. Further, in this treatment, we observed lower levels of the nonstructural protein 5 (NS5) and RNA-directed RNA polymerase (RdRp) protein. Lastly, a significant decrease in arginine levels, an essential requirement for viral replication and progression of viral infection was observed. Conclusions/SignificanceThis study provides insights into the molecular basis of E. anophelis antiviral phenotype. These findings improve our knowledge of how microbes and viruses interact to impact viral replication. In the future, our findings can be utilized to unravel the mechanism behind the antiviral phenotype of E. anophelis, and this can help develop novel paradigms for viral therapeutics. AUTHOR SUMMARYZika is a re-emerging disease and is endemic in many regions of sub-Saharan Africa, Asia and Latin America. It remains a major public health threat and lacks FDA-approved therapeutics or vaccines, hence the urgent need for the identification of alternative approaches that limit the transmission of the pathogens by its primary vector, Aedes spp. The microbial communities residing in the mosquito midgut play a key role in determining the outcome of mosquito pathogen infection. Flavobacteria dominates the mosquito midgut including Elizabethkingia, which is a gram-negative bacillus prevalent in Aedes and Anopheles species of mosquitoes. E. anophelis, a poorly studied midgut microbe, has a broad-spectrum antiviral phenotype, yet the mechanism of its antiviral action is unknown. In this study, we have identified several pathways as well as Zika virus proteins perturbed when the Zika virus is cultivated in the presence of E. anophelis. Our findings do not only provide insights into microbial, virus interaction but could be harnessed to develop novel antiviral tools.

Matching journals

The top 3 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.